Emcure plea to direct NPPA to review HIV drugs price junked by DoP Farhat Nasim3 Feb 2020 8:11 AM GMTNew Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
NPPA fixes retail price of 14 drug formulations; Details Farhat Nasim13 Nov 2019 5:53 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
DOP junks Cipla plea to refix MRP of Tafmune–EM Farhat Nasim2 Sep 2019 11:04 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...
DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug Farhat Nasim18 July 2019 10:28 AM GMTNew Delhi: Through a recent decision, the Department of Pharmaceuticals has rejected the review application filed by Mylan Pharmaceuticals Private...